Lactiplantibacillus plantarum C29 프로바이오틱스와 발효대두분말의 복합물(DW2009)
Lactiplantibacillus plantarum C29 프로바이오틱스와 발효대두분말의 복합물(DW2009)
MFDS recognition no.
2022-43
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
29.0–2009.0 mg/일
Approval holder
동화약품(주)
Approved wording (Korean original)
노화로 저하된 인지능력 개선에 도움을 줄 수 있음
Precautions (Korean original)
영·유아, 어린이, 임산부, 수유부는 섭취 시 주의바랍니다.
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.
Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.